CEMATRIX Corporation has announced that its wholly owned operating subsidiaries have executed $4.5 million in new contracts in 2023. Factoring in the $4.5M in contracts executed, converted contracts, the increase in contracts in process of $1.6 million and sales completed to the end of February 2023, the corporation’s backlog has increased to $87.2 million.

CEMATRIX Corporation is a Bristol Investor Relations client and a leading manufacturer and supplier of technologically advanced cellular concrete products in North America.

Read the full press release here: CEMATRIX Announces $4.5 Million in New Contracts as Backlog Continues to Grow